Lyell Immunopharma to Cut Jobs, Close West Hills Plant

Dow Jones

04-01

Lyell Immunopharma, Inc.3.28%

By Sabela Ojea

Lyell Immunopharma is cutting about 73 jobs as a result of its decision to shutter a manufacturing facility it acquired as part of a deal to buy the clinical-stage company ImmPACT Bio last year.

The biotechnology company on Tuesday said that it expects to book expenses of $3 million to $4 million in the second and third quarters of this year.

The company said closure of the West Hills, Calif., facility comes as it expects its center in Bothell, Wash., to have the capacity to provide drugs for the continuing and planned pivotal trials of IMPT-314, and through a potential commercial launch of the treatment.

IMPT-314 is being evaluated in a phase 1/2 clinical trial for the treatment of relapsed/refractory large B-cell lymphoma.

The company also said that Chief Business Officer Matthew Lang has resigned and will leave his position April 13. Lang will remain an adviser to the company until Sept. 30.

Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix

(END) Dow Jones Newswires

April 01, 2025 17:40 ET (21:40 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

no data

没有相关数据

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2524122659"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2524122659\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2524122659?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-02 05:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2524122659","market":"nz","top_or_hot":-1,"title":"Lyell Immunopharma to Cut Jobs, Close West Hills Plant","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Sabela Ojea \n</p>\n<pre>\n \n</pre>\n<p>\n  Lyell Immunopharma is cutting about 73 jobs as a result of its decision to shutter a manufacturing facility it acquired as part of a deal to buy the clinical-stage company ImmPACT Bio last year. \n</p>\n<p>\n  The biotechnology company on Tuesday said that it expects to book expenses of $3 million to $4 million in the second and third quarters of this year. \n</p>\n<p>\n  The company said closure of the West Hills, Calif., facility comes as it expects its center in Bothell, Wash., to have the capacity to provide drugs for the continuing and planned pivotal trials of IMPT-314, and through a potential commercial launch of the treatment. \n</p>\n<p>\n  IMPT-314 is being evaluated in a phase 1/2 clinical trial for the treatment of relapsed/refractory large B-cell lymphoma. \n</p>\n<p>\n  The company also said that Chief Business Officer Matthew Lang has resigned and will leave his position April 13. Lang will remain an adviser to the company until Sept. 30. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 01, 2025 17:40 ET (21:40 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lyell Immunopharma to Cut Jobs, Close West Hills Plant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLyell Immunopharma to Cut Jobs, Close West Hills Plant\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-04-02 05:40</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Sabela Ojea \n</p>\n<pre>\n \n</pre>\n<p>\n  Lyell Immunopharma is cutting about 73 jobs as a result of its decision to shutter a manufacturing facility it acquired as part of a deal to buy the clinical-stage company ImmPACT Bio last year. \n</p>\n<p>\n  The biotechnology company on Tuesday said that it expects to book expenses of $3 million to $4 million in the second and third quarters of this year. \n</p>\n<p>\n  The company said closure of the West Hills, Calif., facility comes as it expects its center in Bothell, Wash., to have the capacity to provide drugs for the continuing and planned pivotal trials of IMPT-314, and through a potential commercial launch of the treatment. \n</p>\n<p>\n  IMPT-314 is being evaluated in a phase 1/2 clinical trial for the treatment of relapsed/refractory large B-cell lymphoma. \n</p>\n<p>\n  The company also said that Chief Business Officer Matthew Lang has resigned and will leave his position April 13. Lang will remain an adviser to the company until Sept. 30. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 01, 2025 17:40 ET (21:40 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4505","symbol_name":"高瓴资本持仓","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2524122659","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2524122659","pubTimestamp":1743543600,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Lyell Immunopharma is cutting about 73 jobs as a result of its decision to shutter a manufacturing facility it acquired as part of a deal to buy the clinical-stage company ImmPACT Bio last year.The biotechnology company on Tuesday said that it expects to book expenses of $3 million to $4 million in the second and third quarters of this year.The company said closure of the West Hills, Calif., facility comes as it expects its center in Bothell, Wash., to have the capacity to provide drugs for the continuing and planned pivotal trials of IMPT-314, and through a potential commercial launch of the treatment.The company also said that Chief Business Officer Matthew Lang has resigned and will leave his position April 13. Lang will remain an adviser to the company until Sept. 30.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4505":"高瓴资本持仓","BK4139":"生物科技","LYEL":"Lyell Immunopharma, Inc.","BK4539":"次新股"},"translate_title":"Lyell Immunopharma将裁员并关闭西山工厂","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LYEL":1},"content_text":"By Sabela Ojea \n\n\n \n\n\n  Lyell Immunopharma is cutting about 73 jobs as a result of its decision to shutter a manufacturing facility it acquired as part of a deal to buy the clinical-stage company ImmPACT Bio last year. \n\n\n  The biotechnology company on Tuesday said that it expects to book expenses of $3 million to $4 million in the second and third quarters of this year. \n\n\n  The company said closure of the West Hills, Calif., facility comes as it expects its center in Bothell, Wash., to have the capacity to provide drugs for the continuing and planned pivotal trials of IMPT-314, and through a potential commercial launch of the treatment. \n\n\n  IMPT-314 is being evaluated in a phase 1/2 clinical trial for the treatment of relapsed/refractory large B-cell lymphoma. \n\n\n  The company also said that Chief Business Officer Matthew Lang has resigned and will leave his position April 13. Lang will remain an adviser to the company until Sept. 30. \n\n\n \n\n\n  Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 01, 2025 17:40 ET (21:40 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}

如果下载按钮点击无跳转，请点击右上角菜单选择 “在浏览器打开”

立即咨询
下载APP
扫码下载APP